Trinidad/Tobago: free drugs for seniors, poor

10 March 2003

Trinidad and Tobago is to introduce a new Chronic Disease AssistancePlan which will provide around 100,000 poor and elderly people with free health care and medication, according to Health Minister Colm Imbert, who estimated that the plan will cost the government about $15 million annually.

In the first phase of the CDAP, senior citizens and poor people will be entitled to receive 20 drugs for the treatment of diabetes, hypertension, glaucoma and some cardiac diseases, the Caribbean Media Corp news agency has reported.

The Minister stated that "leakage and mismanagement" would be dealt with, while the country's Pharmacy Board has warned that it will take punitive action against any pharmacy that violates the principles of the plan. More than 500 pharmacists, 230 private pharmacies and 400 doctors in private practice will take part in the program, with prescriptions being filled at either private or public institutions, he added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight